Mode
Text Size
Log in / Sign up

Mobile app plus group sessions showed feasibility in Malaysian women with gestational diabetes

Mobile app plus group sessions showed feasibility in Malaysian women with gestational diabetes
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider feasibility of full-scale RCT for digital GDM interventions in Malaysia.

This feasibility randomized controlled trial evaluated a digital health intervention among 60 women with gestational diabetes mellitus in Malaysia. The study population consisted of women who were eligible for the trial, from which 60 (9%) consented and were randomised out of 294 eligible participants. The intervention comprised mobile application modules addressing diet, physical activity, and mental health, combined with dietitian-led group sessions and motivational text messages. The comparator group received usual gestational diabetes care.

The primary outcome measured feasibility metrics, including consent, eligibility, randomisation, and provision of outcome data. Secondary outcomes included biomedical and mental health measures. At each follow-up, 85% of participants completed biomedical outcomes. The study followed participants for 6.0 months. No treatment effect was observed for biomedical outcomes or mental health outcomes. Absolute numbers for these secondary results were not reported.

Safety and tolerability data were not reported, and discontinuations were not reported. The study was a feasibility trial, meaning effectiveness is unclear. Key limitations include the feasibility-only design and the absence of reported adverse events. The primary outcomes were feasibility metrics rather than clinical efficacy. Funding or conflicts of interest were not reported.

The practice relevance suggests feasibility to conduct a full-scale RCT. However, the effectiveness of diabetes prevention interventions post-GDM in this setting is unclear. The study does not establish causality for the intervention on biomedical or secondary outcomes.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up6.0 mo
PublishedMay 2026
View Original Abstract ↓
AIMS: The prevalence of gestational diabetes mellitus (GDM) in Malaysia is estimated at 9-18%. Although GDM is associated with increased and potentially modifiable risk of developing type 2 diabetes, the effectiveness of diabetes prevention interventions (DPI) post-GDM in this setting is unclear. To evaluate the feasibility of conducting a future full-scale, two-arm, parallel, randomised controlled trial (RCT) of a DPI in women with GDM set in Malaysia. METHODS: Women in both arms received usual GDM care. Women in the intervention arm also received modules on diet, physical activity, and mental health via a mobile application, over six months post-partum, plus dietitian-led group sessions and motivational text messages. The primary feasibility outcomes included the proportion of women who consented, were eligible and randomised and provided outcome data. We measured biomedical and mental health outcomes for a full-scale RCT at four time points: baseline before randomisation (approximately 30 weeks' gestation), 36 weeks' gestation and 3- and 6-months postpartum. RESULTS: We screened 660 women with GDM, 294 (45%) consented for eligibility screening, of whom 164 (24.9%) were eligible and 60 (9%) consented and were randomised. The proportion who completed biomedical outcomes was 85% at each follow-up. There was no treatment effect on any other biomedical outcomes or secondary outcomes. CONCLUSIONS: The participation rate was in keeping with previous DPI trials and the attrition rate was low, suggesting it is feasible to conduct a full-scale RCT.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.